Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Katoh

Showing results (251-260 of 265) with videos related to

Pageof 27
Sort By:
Kidney International|January 1, 1997
Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPDM Nakayama, Y Kawaguchi, K Yamada, et al.
Allergy|September 16, 2017
Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic miceM Ueta, J Hamuro, H Nishigaki, et al.
The British Journal of Dermatology|February 6, 2019
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trialsA Blauvelt, D Rosmarin, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2017
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasisA Blauvelt, K A Papp, H Sofen, et al.
Archives of Dermatological Research|July 11, 2023
Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting reportM E Jacobson, K S Thomas, C J Apfelbacher, et al.
The British Journal of Dermatology|September 30, 2019
Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trialsN Katoh, Y Kataoka, H Saeki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2023
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND studyK Reich, J I Silverberg, K A Papp, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 19, 2024
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of useM E Jacobson, R Y Morimoto, Y A Leshem, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 14, 2020
Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trialsT Bieber, J P Thyssen, K Reich, et al.
The British Journal of Dermatology|August 27, 2014
Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8M Furue, D Onozuka, S Takeuchi, et al.
Pageof 27

Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Kidney International|January 1, 1997
Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPDM Nakayama, Y Kawaguchi, K Yamada, et al.
Allergy|September 16, 2017
Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic miceM Ueta, J Hamuro, H Nishigaki, et al.
The British Journal of Dermatology|February 6, 2019
Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trialsA Blauvelt, D Rosmarin, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 13, 2017
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasisA Blauvelt, K A Papp, H Sofen, et al.
Archives of Dermatological Research|July 11, 2023
Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting reportM E Jacobson, K S Thomas, C J Apfelbacher, et al.
The British Journal of Dermatology|September 30, 2019
Efficacy and safety of dupilumab in Japanese adults with moderate-to-severe atopic dermatitis: a subanalysis of three clinical trialsN Katoh, Y Kataoka, H Saeki, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2023
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND studyK Reich, J I Silverberg, K A Papp, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 19, 2024
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of useM E Jacobson, R Y Morimoto, Y A Leshem, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 14, 2020
Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trialsT Bieber, J P Thyssen, K Reich, et al.
The British Journal of Dermatology|August 27, 2014
Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8M Furue, D Onozuka, S Takeuchi, et al.
Pageof 27